"Together, Incannex and APIRx will form the world’s largest portfolio of patented medicinal cannabinoid drug formulations and psychedelic treatment protocols."
Can anyone say... acquisition target?
IHL Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held